The function of nicotinamide phosphoribosyltransferase in the heart

DNA Repair

Volumn 23, Issue , 2014, Pages 64-68

  Hsu, Chiao Po ^b   Yamamoto, Takanobu ^a   Oka, Shinichi ^a   Sadoshima, Junichi ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Apoptosis; Heart; Ischemia; NAD+; Reperfusion; Sirt1

Indexed keywords

NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CELL DEATH; GENE OVEREXPRESSION; HEART; HEART MUSCLE METABOLISM; HEART PROTECTION; HEART STRESS; HEART VENTRICLE HYPERTROPHY; HUMAN; NONHUMAN; REPERFUSION INJURY; UPREGULATION; ANIMAL; CARDIOMEGALY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HEART MUSCLE; HEART MUSCLE ISCHEMIA; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; AUTOPHAGY; CARDIOMEGALY; GENE EXPRESSION REGULATION; HUMANS; MICE, TRANSGENIC; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

EID: 84919391963     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2014.08.005     Document Type: Article

References (51)

1. Virag L., Szabo C. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol. Rev. 2002, 54:375-429.
2. Imai S., Armstrong C.M., Kaeberlein M., Guarente L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 2000, 403:795-800.
3. Guarente L. Sir2 links chromatin silencing, metabolism, and aging. Genes Dev. 2000, 14:1021-1026.
4. Ha C.W., Huh W.K. The implication of Sir2 in replicative aging and senescence in Saccharomyces cerevisiae. Aging (Albany NY) 2011, 3:319-324.
5. Revollo J.R., Grimm A.A., Imai S. The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals. Curr. Opin. Gastroenterol. 2007, 23:164-170.
6. Billington R.A., Genazzani A.A., Travelli C., Condorelli F. NAD depletion by FK866 induces autophagy. Autophagy 2008, 4:385-387.
7. Ying W., Garnier P., Swanson R.A. NAD+ repletion prevents PARP-1-induced glycolytic blockade and cell death in cultured mouse astrocytes. Biochem. Biophys. Res. Commun. 2003, 308:809-813.
8. Revollo J.R., Grimm A.A., Imai S. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J. Biol. Chem. 2004, 279:50754-50763.
9. Rongvaux A., Shea R.J., Mulks M.H., Gigot D., Urbain J., Leo O., Andris F. Pre-B-cell colony-enhancing factor, whose expression is up-regulated in activated lymphocytes, is a nicotinamide phosphoribosyltransferase, a cytosolic enzyme involved in NAD biosynthesis. Eur. J. Immunol. 2002, 32:3225-3234.
10. Emanuelli M., Carnevali F., Saccucci F., Pierella F., Amici A., Raffaelli N., Magni G. Molecular cloning, chromosomal localization, tissue mRNA levels, bacterial expression, and enzymatic properties of human NMN adenylyltransferase. J. Biol. Chem. 2001, 276:406-412.
11. Schweiger M., Hennig K., Lerner F., Niere M., Hirsch-Kauffmann M., Specht T., Weise C., Oei S.L., Ziegler M. Characterization of recombinant human nicotinamide mononucleotide adenylyl transferase (NMNAT), a nuclear enzyme essential for NAD synthesis. FEBS Lett. 2001, 492:95-100.
12. Samal B., Sun Y., Stearns G., Xie C., Suggs S., McNiece I. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol. Cell. Biol. 1994, 14:1431-1437.
13. Tanaka M., Nozaki M., Fukuhara A., Segawa K., Aoki N., Matsuda M., Komuro R., Shimomura I. Visfatin is released from 3T3-L1 adipocytes via a non-classical pathway. Biochem. Biophys. Res. Commun. 2007, 359:194-201.
14. Pillai V.B., Sundaresan N.R., Kim G., Samant S., Moreno-Vinasco L., Garcia J.G., Gupta M.P. Nampt secreted from cardiomyocytes promotes development of cardiac hypertrophy and adverse ventricular remodeling. Am. J. Physiol. Heart Circ. Physiol. 2013, 304:H415-H426.
15. Fukuhara A., Matsuda M., Nishizawa M., Segawa K., Tanaka M., Kishimoto K., Matsuki Y., Murakami M., Ichisaka T., Murakami H., Watanabe E., Takagi T., Akiyoshi M., Ohtsubo T., Kihara S., Yamashita S., Makishima M., Funahashi T., Yamanaka S., Hiramatsu R., Matsuzawa Y., Shimomura I. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005, 307:426-430.
16. Song H.K., Lee M.H., Kim B.K., Park Y.G., Ko G.J., Kang Y.S., Han J.Y., Han S.Y., Han K.H., Kim H.K., Cha D.R. Visfatin: a new player in mesangial cell physiology and diabetic nephropathy. Am. J. Physiol. Renal Physiol. 2008, 295:F1485-F1494.
17. Revollo J.R., Korner A., Mills K.F., Satoh A., Wang T., Garten A., Dasgupta B., Sasaki Y., Wolberger C., Townsend R.R., Milbrandt J., Kiess W., Imai S. Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab. 2007, 6:363-375.
18. Montecucco F., Bauer I., Braunersreuther V., Bruzzone S., Akhmedov A., Luscher T.F., Speer T., Poggi A., Mannino E., Pelli G., Galan K., Bertolotto M., Lenglet S., Garuti A., Montessuit C., Lerch R., Pellieux C., Vuilleumier N., Dallegri F., Mage J., Sebastian C., Mostoslavsky R., Gayet-Ageron A., Patrone F., Mach F., Nencioni A. Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarction. Antioxid. Redox Signal. 2013, 18:630-641.
19. Martin P.R., Shea R.J., Mulks M.H. Identification of a plasmid-encoded gene from Haemophilus ducreyi which confers NAD independence. J. Bacteriol. 2001, 183:1168-1174.
20. Dahl T.B., Holm S., Aukrust P., Halvorsen B. Visfatin/NAMPT: a multifaceted molecule with diverse roles in physiology and pathophysiology. Annu. Rev. Nutr. 2012, 32:229-243.
21. Hsu C.P., Oka S., Shao D., Hariharan N., Sadoshima J. Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes. Circ. Res. 2009, 105:481-491.
22. Pillai V.B., Sundaresan N.R., Kim G., Gupta M., Rajamohan S.B., Pillai J.B., Samant S., Ravindra P.V., Isbatan A., Gupta M.P. Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway. J. Biol. Chem. 2010, 285:3133-3144.
23. Nakamura M., Bhatnagar A., Sadoshima J. Overview of pyridine nucleotides review series. Circ. Res. 2012, 111:604-610.
24. Oka S., Hsu C.P., Sadoshima J. Regulation of cell survival and death by pyridine nucleotides. Circ. Res. 2012, 111:611-627.
25. Horton J.K., Stefanick D.F., Wilson S.H. Involvement of poly(ADP-ribose) polymerase activity in regulating Chk1-dependent apoptotic cell death. DNA Repair (Amst) 2005, 4:1111-1120.
26. Anderson R.M., Bitterman K.J., Wood J.G., Medvedik O., Sinclair D.A., Nicotinamide PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae. Nature 2003, 423:181-185.
27. Hsu C.P., Zhai P., Yamamoto T., Maejima Y., Matsushima S., Hariharan N., Shao D., Takagi H., Oka S., Sadoshima J. Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation 2010, 122:2170-2182.
28. Alcendor R.R., Kirshenbaum L.A., Imai S., Sadoshima J. Sir2α, a longevity factor and a class III histone decetylase, is an essential endogenous inhibitor of apoptosis in cardiac myocytes. Circ. Res. 2004, 95:971-980.
29. Yamamoto T., Sadoshima J. Protection of the heart against ischemia/reperfusion by silent information regulator 1. Trends Cardiovasc. Med. 2011, 21:27-32.
30. Lim S.Y., Davidson S.M., Paramanathan A.J., Smith C.C., Yellon D.M., Hausenloy D.J. The novel adipocytokine visfatin exerts direct cardioprotective effects. J. Cell. Mol. Med. 2008, 12:1395-1403.
31. Xiao J., Sun B., Li M., Wu Y., Sun X.B. A novel adipocytokine visfatin protects against H(2)O(2)-induced myocardial apoptosis: a missing link between obesity and cardiovascular disease. J. Cell. Physiol. 2013, 228:495-501.
32. Ramsey K.M., Yoshino J., Brace C.S., Abrassart D., Kobayashi Y., Marcheva B., Hong H.K., Chong J.L., Buhr E.D., Lee C., Takahashi J.S., Imai S., Bass J. Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis. Science 2009, 324:651-654.
33. Nakahata Y., Sahar S., Astarita G., Kaluzova M., Sassone-Corsi P. Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1. Science 2009, 324:654-657.
34. Um J.H., Pendergast J.S., Springer D.A., Foretz M., Viollet B., Brown A., Kim M.K., Yamazaki S., Chung J.H. AMPK regulates circadian rhythms in a tissue- and isoform-specific manner. PLoS ONE 2011, 6:e18450.
35. Mizushima N., Klionsky D.J. Protein turnover via autophagy: implications for metabolism. Annu. Rev. Nutr. 2007, 27:19-40.
36. Bjorkoy G., Lamark T., Johansen T. p62/SQSTM1: a missing link between protein aggregates and the autophagy machinery. Autophagy 2006, 2:138-139.
37. Nakai A., Yamaguchi O., Takeda T., Higuchi Y., Hikoso S., Taniike M., Omiya S., Mizote I., Matsumura Y., Asahi M., Nishida K., Hori M., Mizushima N., Otsu K. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat. Med. 2007, 13:619-624.
38. Wang Q.J., Ding Y., Kohtz D.S., Mizushima N., Cristea I.M., Rout M.P., Chait B.T., Zhong Y., Heintz N., Yue Z. Induction of autophagy in axonal dystrophy and degeneration. J. Neurosci. 2006, 26:8057-8068.
39. Lee I.H., Cao L., Mostoslavsky R., Lombard D.B., Liu J., Bruns N.E., Tsokos M., Alt F.W., Finkel T. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:3374-3379.
40. Cea M., Cagnetta A., Fulciniti M., Tai Y.T., Hideshima T., Chauhan D., Roccaro A., Sacco A., Calimeri T., Cottini F., Jakubikova J., Kong S.Y., Patrone F., Nencioni A., Gobbi M., Richardson P., Munshi N., Anderson K.C. Targeting NAD+ salvage pathway induces autophagy in multiple myeloma cells via mTORC1 and extracellular signal-regulated kinase (ERK1/2) inhibition. Blood 2012, 120:3519-3529.
41. Belenky P., Bogan K.L., Brenner C. NAD+ metabolism in health and disease. Trends Biochem. Sci. 2007, 32:12-19.
42. Van Beijnum J.R., Moerkerk P.T., Gerbers A.J., De Bruine A.P., Arends J.W., Hoogenboom H.R., Hufton S.E. Target validation for genomics using peptide-specific phage antibodies: a study of five gene products overexpressed in colorectal cancer. Int. J. Cancer 2002, 101:118-127.
43. Hufton S.E., Moerkerk P.T., Brandwijk R., de Bruine A.P., Arends J.W., Hoogenboom H.R. A profile of differentially expressed genes in primary colorectal cancer using suppression subtractive hybridization. FEBS Lett. 1999, 463:77-82.
44. Wang P., Guan Y.F., Du H., Zhai Q.W., Su D.F., Miao C.Y. Induction of autophagy contributes to the neuroprotection of nicotinamide phosphoribosyltransferase in cerebral ischemia. Autophagy 2012, 8:77-87.
45. Cai Y., Yu S.S., Chen S.R., Pi R.B., Gao S., Li H., Ye J.T., Liu P.Q. Nmnat2 protects cardiomyocytes from hypertrophy via activation of SIRT6. FEBS Lett. 2012, 586:866-874.
46. Karamanlidis G., Lee C.F., Garcia-Menendez L., Kolwicz S.C., Suthammarak W., Gong G., Sedensky M.M., Morgan P.G., Wang W., Tian R. Mitochondrial complex I deficiency increases protein acetylation and accelerates heart failure. Cell Metab. 2013, 18:239-250.
47. Adya R., Tan B.K., Chen J., Randeva H.S. Nuclear factor-kappaB induction by visfatin in human vascular endothelial cells: its role in MMP-2/9 production and activation. Diabetes Care 2008, 31:758-760.
48. Li Y., Zhang Y., Dorweiler B., Cui D., Wang T., Woo C.W., Brunkan C.S., Wolberger C., Imai S., Tabas I. Extracellular Nampt promotes macrophage survival via a nonenzymatic interleukin-6/STAT3 signaling mechanism. J. Biol. Chem. 2008, 283:34833-34843.
49. Canto C., Houtkooper R.H., Pirinen E., Youn D.Y., Oosterveer M.H., Cen Y., Fernandez-Marcos P.J., Yamamoto H., Andreux P.A., Cettour-Rose P., Gademann K., Rinsch C., Schoonjans K., Sauve A.A., Auwerx J. The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. Cell Metab. 2012, 15:838-847.
50. Khan N.A., Auranen M., Paetau I., Pirinen E., Euro L., Forsstrom S., Pasila L., Velagapudi V., Carroll C.J., Auwerx J., Suomalainen A. Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3. EMBO Mol. Med. 2014.
51. Yoshino J., Mills K.F., Yoon M.J., Imai S. Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. 2011, 14:528-536.